LB Pharmaceuticals Inc. Files Initial Beneficial Ownership Statement for Chief Commercial Officer Kaya Kamlesh Pai Panandiker
LB Pharmaceuticals Inc. has filed an initial statement of beneficial ownership with the U.S. SEC, listing Kaya Kamlesh Pai Panandiker as the beneficial owner and Chief Commercial Officer. This filing is accessible via EDGAR, the SEC's system. The information was published on November 18, 2025, and is for informational purposes only, not financial or legal advice.
LB Pharmaceuticals Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing lists Kaya Kamlesh Pai Panandiker as the beneficial owner, serving as Chief Commercial Officer of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LB Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002095250-25-000002), on November 18, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
